| 000 | 01350 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250516125352.0 | ||
| 264 | 0 | _c20130703 | |
| 008 | 201307s 0 0 eng d | ||
| 022 | _a1875-6212 | ||
| 024 | 7 |
_a10.2174/157016112803520819 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChannon, Keith M | |
| 245 | 0 | 0 |
_aTetrahydrobiopterin: a vascular redox target to improve endothelial function. _h[electronic resource] |
| 260 |
_bCurrent vascular pharmacology _cNov 2012 |
||
| 300 |
_a705-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntioxidants _xtherapeutic use |
| 650 | 0 | 4 |
_aBiopterins _xanalogs & derivatives |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Transgenic |
| 650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
| 650 | 0 | 4 |
_aNitric Oxide Synthase _xmetabolism |
| 650 | 0 | 4 | _aOxidation-Reduction |
| 650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
| 650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 773 | 0 |
_tCurrent vascular pharmacology _gvol. 10 _gno. 6 _gp. 705-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/157016112803520819 _zAvailable from publisher's website |
| 999 |
_c22364446 _d22364446 |
||